FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909241308> ?p ?o ?g. }

• W2909241308 endingPage "571" @default.
• W2909241308 startingPage "563" @default.
• W2909241308 abstract "Atrial fibrillation (AF) reduces quality of life (QoL). We aim to evaluate effects of targeted therapy of underlying conditions on QoL in patients with AF and heart failure (HF).The Routine versus Aggressive risk factor driven upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study randomized patients with early persistent AF and HF to targeted or conventional therapy. Both groups received guideline-driven treatment. The targeted group received four additional therapies: mineralocorticoid receptor antagonists; statins; angiotensin converting enzyme inhibitors and/or receptor blockers; and cardiac rehabilitation including physical activity, dietary restrictions, and counselling. Quality of life was analysed in 230 patients at baseline and 1 year with available Medical Outcomes Study Short-Form Health Survey (SF-36), University of Toronto AF Severity Scale (AFSS) questionnaires, and European Heart Rhythm Association (EHRA) class. Improvements in SF-36 subscales were larger in the targeted group for physical functioning (Δ12 ± 19 vs. Δ6 ± 22, P = 0.007), physical role limitations (Δ32 ± 41 vs. Δ17 ± 45, P = 0.018), and general health (Δ8 ± 16 vs. Δ0 ± 17, P < 0.001). Dyspnoea at rest improved more (Δ-0.8 ± 1.3 vs. Δ-0.4 ± 1.2, P = 0.018) and EHRA class was lower at 1-year follow-up in the targeted group. Patients with AF at 1 year, improvement in physical functioning (Δ9 ± 9 vs. Δ-3 ± 16, P = 0.001), general health (Δ7 ± 16 vs. Δ-7 ± 19, P = 0.004), and social functioning (Δ6 ± 23 vs. Δ-4 ± 16, P = 0.041) were larger in the targeted group.A strategy aiming to treat underlying conditions improved QoL more compared with conventional therapy in patients with early persistent AF and HF. Its benefit was even observed in patients in AF at 1 year.Clinicaltrials.gov NCT00877643." @default.
• W2909241308 created "2019-01-25" @default.
• W2909241308 creator A5003578699 @default.
• W2909241308 creator A5005773814 @default.
• W2909241308 creator A5011411516 @default.
• W2909241308 creator A5013360666 @default.
• W2909241308 creator A5033537614 @default.
• W2909241308 creator A5033884631 @default.
• W2909241308 creator A5043836827 @default.
• W2909241308 creator A5062603116 @default.
• W2909241308 creator A5063125852 @default.
• W2909241308 creator A5064509705 @default.
• W2909241308 creator A5067090261 @default.
• W2909241308 creator A5069496306 @default.
• W2909241308 creator A5070836865 @default.
• W2909241308 creator A5071844230 @default.
• W2909241308 creator A5083563269 @default.
• W2909241308 creator A5085426140 @default.
• W2909241308 creator A5090763481 @default.
• W2909241308 date "2019-01-09" @default.
• W2909241308 modified "2023-09-24" @default.
• W2909241308 title "Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study" @default.
• W2909241308 cites W1963940525 @default.
• W2909241308 cites W1969667526 @default.
• W2909241308 cites W1973633212 @default.
• W2909241308 cites W2003239266 @default.
• W2909241308 cites W2037377025 @default.
• W2909241308 cites W2040051636 @default.
• W2909241308 cites W2047026973 @default.
• W2909241308 cites W2047949954 @default.
• W2909241308 cites W2073186247 @default.
• W2909241308 cites W2096045617 @default.
• W2909241308 cites W2100922457 @default.
• W2909241308 cites W2123844496 @default.
• W2909241308 cites W2295209411 @default.
• W2909241308 cites W2427094903 @default.
• W2909241308 cites W2509795914 @default.
• W2909241308 cites W2789203914 @default.
• W2909241308 cites W2791489728 @default.
• W2909241308 cites W3150595609 @default.
• W2909241308 cites W57921783 @default.
• W2909241308 cites W776843255 @default.
• W2909241308 doi "https://doi.org/10.1093/europace/euy311" @default.
• W2909241308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30629160" @default.
• W2909241308 hasPublicationYear "2019" @default.
• W2909241308 type Work @default.
• W2909241308 sameAs 2909241308 @default.
• W2909241308 citedByCount "19" @default.
• W2909241308 countsByYear W29092413082019 @default.
• W2909241308 countsByYear W29092413082020 @default.
• W2909241308 countsByYear W29092413082021 @default.
• W2909241308 countsByYear W29092413082022 @default.
• W2909241308 countsByYear W29092413082023 @default.
• W2909241308 crossrefType "journal-article" @default.
• W2909241308 hasAuthorship W2909241308A5003578699 @default.
• W2909241308 hasAuthorship W2909241308A5005773814 @default.
• W2909241308 hasAuthorship W2909241308A5011411516 @default.
• W2909241308 hasAuthorship W2909241308A5013360666 @default.
• W2909241308 hasAuthorship W2909241308A5033537614 @default.
• W2909241308 hasAuthorship W2909241308A5033884631 @default.
• W2909241308 hasAuthorship W2909241308A5043836827 @default.
• W2909241308 hasAuthorship W2909241308A5062603116 @default.
• W2909241308 hasAuthorship W2909241308A5063125852 @default.
• W2909241308 hasAuthorship W2909241308A5064509705 @default.
• W2909241308 hasAuthorship W2909241308A5067090261 @default.
• W2909241308 hasAuthorship W2909241308A5069496306 @default.
• W2909241308 hasAuthorship W2909241308A5070836865 @default.
• W2909241308 hasAuthorship W2909241308A5071844230 @default.
• W2909241308 hasAuthorship W2909241308A5083563269 @default.
• W2909241308 hasAuthorship W2909241308A5085426140 @default.
• W2909241308 hasAuthorship W2909241308A5090763481 @default.
• W2909241308 hasBestOaLocation W29092413082 @default.
• W2909241308 hasConcept C126322002 @default.
• W2909241308 hasConcept C142724271 @default.
• W2909241308 hasConcept C159110408 @default.
• W2909241308 hasConcept C164705383 @default.
• W2909241308 hasConcept C168563851 @default.
• W2909241308 hasConcept C1862650 @default.
• W2909241308 hasConcept C189135053 @default.
• W2909241308 hasConcept C2778094803 @default.
• W2909241308 hasConcept C2778198053 @default.
• W2909241308 hasConcept C2778525890 @default.
• W2909241308 hasConcept C2778818304 @default.
• W2909241308 hasConcept C2779161974 @default.
• W2909241308 hasConcept C2779951463 @default.
• W2909241308 hasConcept C2780182762 @default.
• W2909241308 hasConcept C71924100 @default.
• W2909241308 hasConceptScore W2909241308C126322002 @default.
• W2909241308 hasConceptScore W2909241308C142724271 @default.
• W2909241308 hasConceptScore W2909241308C159110408 @default.
• W2909241308 hasConceptScore W2909241308C164705383 @default.
• W2909241308 hasConceptScore W2909241308C168563851 @default.
• W2909241308 hasConceptScore W2909241308C1862650 @default.
• W2909241308 hasConceptScore W2909241308C189135053 @default.
• W2909241308 hasConceptScore W2909241308C2778094803 @default.
• W2909241308 hasConceptScore W2909241308C2778198053 @default.
• W2909241308 hasConceptScore W2909241308C2778525890 @default.
• W2909241308 hasConceptScore W2909241308C2778818304 @default.

• next